 | • レポートコード：D005-00495 • 出版社/出版日：GlobalInfoResearch / 2020年5月29日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、105ページ • 納品方法：Eメール • 産業分類：医療・製薬 |
| Single User | ￥522,000 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥783,000 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,044,000 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、ヒトヘルペスウイルス5型（HHV-5）薬の世界市場を広く調査・分析し、今後の市場展望をまとめております。ヒトヘルペスウイルス5型（HHV-5）薬の種類別市場規模（ガンシクロビル、バレリアンギリビル薬、アシクロビル薬、バラシクロビル薬、ホスカルネットナトリウム薬）、用途別市場規模（免疫不全群、臓器移植群、CMVヘルペス群）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・市場概要 ・企業情報（販売量、市場シェア、製品概要、SWOT分析）：Roche、Haikou Kellett、Hubei Branch benefits medicine、Livzon Pharmaceuticals、Chongqing Winbond (acquisition of Sichuan Mingxin)、Sichuan Cologne Pharmaceutical、Chongqing Fu'an Pharmaceutical、Upright and clear、GlaxoSmithKline、On the drug new Asia、Shandong Luo Xin Pharmaceutical、Wuhan Hualong、Yangtze River Pharmaceutical、Qianjiang Pharmaceuticals ・地域別グローバル市場分析 2015年-2020年 ・ヒトヘルペスウイルス5型（HHV-5）薬の北米市場（アメリカ、カナダ、メキシコ） ・ヒトヘルペスウイルス5型（HHV-5）薬のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・ヒトヘルペスウイルス5型（HHV-5）薬のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・ヒトヘルペスウイルス5型（HHV-5）薬の南米市場（ブラジル、アルゼンチン） ・ヒトヘルペスウイルス5型（HHV-5）薬の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：ガンシクロビル、バレリアンギリビル薬、アシクロビル薬、バラシクロビル薬、ホスカルネットナトリウム薬 ・用途別分析：免疫不全群、臓器移植群、CMVヘルペス群 ・地域別市場規模予測 2021年-2025年 ・販売チャネル、流通業者、代理店 ・調査の結果・結論 |
Market Overview
The global Human Herpersvirus 5 (HHV-5) Drug market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Human Herpersvirus 5 (HHV-5) Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Human Herpersvirus 5 (HHV-5) Drug market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Human Herpersvirus 5 (HHV-5) Drug market has been segmented into:
Ganciclovir
Valerian Gilivir Drugs
Acyclovir Drugs
Valacyclovir Drugs
Foscarnet Sodium Drugs
By Application, Human Herpersvirus 5 (HHV-5) Drug has been segmented into:
Immunodeficiency Crowd
Organ Transplant Crowd
CMV Herpes Crowd
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Human Herpersvirus 5 (HHV-5) Drug market presented in the report. This section sheds light on the sales growth of different regional and country-level Human Herpersvirus 5 (HHV-5) Drug markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Human Herpersvirus 5 (HHV-5) Drug market.
The report offers in-depth assessment of the growth and other aspects of the Human Herpersvirus 5 (HHV-5) Drug market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and Human Herpersvirus 5 (HHV-5) Drug Market Share Analysis
Human Herpersvirus 5 (HHV-5) Drug competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Human Herpersvirus 5 (HHV-5) Drug sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Human Herpersvirus 5 (HHV-5) Drug sales, revenue and market share for each player covered in this report.
The major players covered in Human Herpersvirus 5 (HHV-5) Drug are:
Roche
Haikou Kellett
Hubei Branch benefits medicine
Livzon Pharmaceuticals
Chongqing Winbond (acquisition of Sichuan Mingxin)
Sichuan Cologne Pharmaceutical
Chongqing Fu’an Pharmaceutical
Upright and clear
GlaxoSmithKline
On the drug new Asia
Shandong Luo Xin Pharmaceutical
Wuhan Hualong
Yangtze River Pharmaceutical
Qianjiang Pharmaceuticals
Table of Contents
1 Human Herpersvirus 5 (HHV-5) Drug Market Overview
1.1 Product Overview and Scope of Human Herpersvirus 5 (HHV-5) Drug
1.2 Classification of Human Herpersvirus 5 (HHV-5) Drug by Type
1.2.1 Global Human Herpersvirus 5 (HHV-5) Drug Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Human Herpersvirus 5 (HHV-5) Drug Revenue Market Share by Type in 2019
1.2.3 Ganciclovir
1.2.4 Valerian Gilivir Drugs
1.2.5 Acyclovir Drugs
1.2.6 Valacyclovir Drugs
1.2.7 Foscarnet Sodium Drugs
1.3 Global Human Herpersvirus 5 (HHV-5) Drug Market by Application
1.3.1 Overview: Global Human Herpersvirus 5 (HHV-5) Drug Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Immunodeficiency Crowd
1.3.3 Organ Transplant Crowd
1.3.4 CMV Herpes Crowd
1.4 Global Human Herpersvirus 5 (HHV-5) Drug Market by Regions
1.4.1 Global Human Herpersvirus 5 (HHV-5) Drug Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Human Herpersvirus 5 (HHV-5) Drug (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Human Herpersvirus 5 (HHV-5) Drug Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Human Herpersvirus 5 (HHV-5) Drug Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Human Herpersvirus 5 (HHV-5) Drug Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Human Herpersvirus 5 (HHV-5) Drug Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Human Herpersvirus 5 (HHV-5) Drug Status and Prospect (2015-2025)
2 Company Profiles
2.1 Roche
2.1.1 Roche Details
2.1.2 Roche Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Roche SWOT Analysis
2.1.4 Roche Product and Services
2.1.5 Roche Human Herpersvirus 5 (HHV-5) Drug Revenue, Gross Margin and Market Share (2018-2019)
2.2 Haikou Kellett
2.2.1 Haikou Kellett Details
2.2.2 Haikou Kellett Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Haikou Kellett SWOT Analysis
2.2.4 Haikou Kellett Product and Services
2.2.5 Haikou Kellett Human Herpersvirus 5 (HHV-5) Drug Revenue, Gross Margin and Market Share (2018-2019)
2.3 Hubei Branch benefits medicine
2.3.1 Hubei Branch benefits medicine Details
2.3.2 Hubei Branch benefits medicine Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Hubei Branch benefits medicine SWOT Analysis
2.3.4 Hubei Branch benefits medicine Product and Services
2.3.5 Hubei Branch benefits medicine Human Herpersvirus 5 (HHV-5) Drug Revenue, Gross Margin and Market Share (2018-2019)
2.4 Livzon Pharmaceuticals
2.4.1 Livzon Pharmaceuticals Details
2.4.2 Livzon Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Livzon Pharmaceuticals SWOT Analysis
2.4.4 Livzon Pharmaceuticals Product and Services
2.4.5 Livzon Pharmaceuticals Human Herpersvirus 5 (HHV-5) Drug Revenue, Gross Margin and Market Share (2018-2019)
2.5 Chongqing Winbond (acquisition of Sichuan Mingxin)
2.5.1 Chongqing Winbond (acquisition of Sichuan Mingxin) Details
2.5.2 Chongqing Winbond (acquisition of Sichuan Mingxin) Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Chongqing Winbond (acquisition of Sichuan Mingxin) SWOT Analysis
2.5.4 Chongqing Winbond (acquisition of Sichuan Mingxin) Product and Services
2.5.5 Chongqing Winbond (acquisition of Sichuan Mingxin) Human Herpersvirus 5 (HHV-5) Drug Revenue, Gross Margin and Market Share (2018-2019)
2.6 Sichuan Cologne Pharmaceutical
2.6.1 Sichuan Cologne Pharmaceutical Details
2.6.2 Sichuan Cologne Pharmaceutical Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Sichuan Cologne Pharmaceutical SWOT Analysis
2.6.4 Sichuan Cologne Pharmaceutical Product and Services
2.6.5 Sichuan Cologne Pharmaceutical Human Herpersvirus 5 (HHV-5) Drug Revenue, Gross Margin and Market Share (2018-2019)
2.7 Chongqing Fu’an Pharmaceutical
2.7.1 Chongqing Fu’an Pharmaceutical Details
2.7.2 Chongqing Fu’an Pharmaceutical Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Chongqing Fu’an Pharmaceutical SWOT Analysis
2.7.4 Chongqing Fu’an Pharmaceutical Product and Services
2.7.5 Chongqing Fu’an Pharmaceutical Human Herpersvirus 5 (HHV-5) Drug Revenue, Gross Margin and Market Share (2018-2019)
2.8 Upright and clear
2.8.1 Upright and clear Details
2.8.2 Upright and clear Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Upright and clear SWOT Analysis
2.8.4 Upright and clear Product and Services
2.8.5 Upright and clear Human Herpersvirus 5 (HHV-5) Drug Revenue, Gross Margin and Market Share (2018-2019)
2.9 GlaxoSmithKline
2.9.1 GlaxoSmithKline Details
2.9.2 GlaxoSmithKline Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 GlaxoSmithKline SWOT Analysis
2.9.4 GlaxoSmithKline Product and Services
2.9.5 GlaxoSmithKline Human Herpersvirus 5 (HHV-5) Drug Revenue, Gross Margin and Market Share (2018-2019)
2.10 On the drug new Asia
2.10.1 On the drug new Asia Details
2.10.2 On the drug new Asia Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 On the drug new Asia SWOT Analysis
2.10.4 On the drug new Asia Product and Services
2.10.5 On the drug new Asia Human Herpersvirus 5 (HHV-5) Drug Revenue, Gross Margin and Market Share (2018-2019)
2.11 Shandong Luo Xin Pharmaceutical
2.11.1 Shandong Luo Xin Pharmaceutical Details
2.11.2 Shandong Luo Xin Pharmaceutical Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Shandong Luo Xin Pharmaceutical SWOT Analysis
2.11.4 Shandong Luo Xin Pharmaceutical Product and Services
2.11.5 Shandong Luo Xin Pharmaceutical Human Herpersvirus 5 (HHV-5) Drug Revenue, Gross Margin and Market Share (2018-2019)
2.12 Wuhan Hualong
2.12.1 Wuhan Hualong Details
2.12.2 Wuhan Hualong Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 Wuhan Hualong SWOT Analysis
2.12.4 Wuhan Hualong Product and Services
2.12.5 Wuhan Hualong Human Herpersvirus 5 (HHV-5) Drug Revenue, Gross Margin and Market Share (2018-2019)
2.13 Yangtze River Pharmaceutical
2.13.1 Yangtze River Pharmaceutical Details
2.13.2 Yangtze River Pharmaceutical Major Business and Total Revenue (Financial Highlights) Analysis
2.13.3 Yangtze River Pharmaceutical SWOT Analysis
2.13.4 Yangtze River Pharmaceutical Product and Services
2.13.5 Yangtze River Pharmaceutical Human Herpersvirus 5 (HHV-5) Drug Revenue, Gross Margin and Market Share (2018-2019)
2.14 Qianjiang Pharmaceuticals
2.14.1 Qianjiang Pharmaceuticals Details
2.14.2 Qianjiang Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.14.3 Qianjiang Pharmaceuticals SWOT Analysis
2.14.4 Qianjiang Pharmaceuticals Product and Services
2.14.5 Qianjiang Pharmaceuticals Human Herpersvirus 5 (HHV-5) Drug Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Human Herpersvirus 5 (HHV-5) Drug Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Human Herpersvirus 5 (HHV-5) Drug Players Market Share
3.2.2 Top 10 Human Herpersvirus 5 (HHV-5) Drug Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Human Herpersvirus 5 (HHV-5) Drug Revenue and Market Share by Regions
4.2 North America Human Herpersvirus 5 (HHV-5) Drug Revenue and Growth Rate (2015-2020)
4.3 Europe Human Herpersvirus 5 (HHV-5) Drug Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Human Herpersvirus 5 (HHV-5) Drug Revenue and Growth Rate (2015-2020)
4.5 South America Human Herpersvirus 5 (HHV-5) Drug Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Human Herpersvirus 5 (HHV-5) Drug Revenue and Growth Rate (2015-2020)
5 North America Human Herpersvirus 5 (HHV-5) Drug Revenue by Countries
5.1 North America Human Herpersvirus 5 (HHV-5) Drug Revenue by Countries (2015-2020)
5.2 USA Human Herpersvirus 5 (HHV-5) Drug Revenue and Growth Rate (2015-2020)
5.3 Canada Human Herpersvirus 5 (HHV-5) Drug Revenue and Growth Rate (2015-2020)
5.4 Mexico Human Herpersvirus 5 (HHV-5) Drug Revenue and Growth Rate (2015-2020)
6 Europe Human Herpersvirus 5 (HHV-5) Drug Revenue by Countries
6.1 Europe Human Herpersvirus 5 (HHV-5) Drug Revenue by Countries (2015-2020)
6.2 Germany Human Herpersvirus 5 (HHV-5) Drug Revenue and Growth Rate (2015-2020)
6.3 UK Human Herpersvirus 5 (HHV-5) Drug Revenue and Growth Rate (2015-2020)
6.4 France Human Herpersvirus 5 (HHV-5) Drug Revenue and Growth Rate (2015-2020)
6.5 Russia Human Herpersvirus 5 (HHV-5) Drug Revenue and Growth Rate (2015-2020)
6.6 Italy Human Herpersvirus 5 (HHV-5) Drug Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Human Herpersvirus 5 (HHV-5) Drug Revenue by Countries
7.1 Asia-Pacific Human Herpersvirus 5 (HHV-5) Drug Revenue by Countries (2015-2020)
7.2 China Human Herpersvirus 5 (HHV-5) Drug Revenue and Growth Rate (2015-2020)
7.3 Japan Human Herpersvirus 5 (HHV-5) Drug Revenue and Growth Rate (2015-2020)
7.4 Korea Human Herpersvirus 5 (HHV-5) Drug Revenue and Growth Rate (2015-2020)
7.5 India Human Herpersvirus 5 (HHV-5) Drug Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Human Herpersvirus 5 (HHV-5) Drug Revenue and Growth Rate (2015-2020)
8 South America Human Herpersvirus 5 (HHV-5) Drug Revenue by Countries
8.1 South America Human Herpersvirus 5 (HHV-5) Drug Revenue by Countries (2015-2020)
8.2 Brazil Human Herpersvirus 5 (HHV-5) Drug Revenue and Growth Rate (2015-2020)
8.3 Argentina Human Herpersvirus 5 (HHV-5) Drug Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Human Herpersvirus 5 (HHV-5) Drug by Countries
9.1 Middle East & Africa Human Herpersvirus 5 (HHV-5) Drug Revenue by Countries (2015-2020)
9.2 Saudi Arabia Human Herpersvirus 5 (HHV-5) Drug Revenue and Growth Rate (2015-2020)
9.3 UAE Human Herpersvirus 5 (HHV-5) Drug Revenue and Growth Rate (2015-2020)
9.4 Egypt Human Herpersvirus 5 (HHV-5) Drug Revenue and Growth Rate (2015-2020)
9.5 South Africa Human Herpersvirus 5 (HHV-5) Drug Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Human Herpersvirus 5 (HHV-5) Drug Revenue and Market Share by Type (2015-2020)
10.2 Global Human Herpersvirus 5 (HHV-5) Drug Market Forecast by Type (2019-2024)
10.3 Ganciclovir Revenue Growth Rate (2015-2025)
10.4 Valerian Gilivir Drugs Revenue Growth Rate (2015-2025)
10.5 Acyclovir Drugs Revenue Growth Rate (2015-2025)
10.6 Valacyclovir Drugs Revenue Growth Rate (2015-2025)
10.7 Foscarnet Sodium Drugs Revenue Growth Rate (2015-2025)
11 Global Human Herpersvirus 5 (HHV-5) Drug Market Segment by Application
11.1 Global Human Herpersvirus 5 (HHV-5) Drug Revenue Market Share by Application (2015-2020)
11.2 Human Herpersvirus 5 (HHV-5) Drug Market Forecast by Application (2019-2024)
11.3 Immunodeficiency Crowd Revenue Growth (2015-2020)
11.4 Organ Transplant Crowd Revenue Growth (2015-2020)
11.5 CMV Herpes Crowd Revenue Growth (2015-2020)
12 Global Human Herpersvirus 5 (HHV-5) Drug Market Size Forecast (2021-2025)
12.1 Global Human Herpersvirus 5 (HHV-5) Drug Market Size Forecast (2021-2025)
12.2 Global Human Herpersvirus 5 (HHV-5) Drug Market Forecast by Regions (2021-2025)
12.3 North America Human Herpersvirus 5 (HHV-5) Drug Revenue Market Forecast (2021-2025)
12.4 Europe Human Herpersvirus 5 (HHV-5) Drug Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Human Herpersvirus 5 (HHV-5) Drug Revenue Market Forecast (2021-2025)
12.6 South America Human Herpersvirus 5 (HHV-5) Drug Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Human Herpersvirus 5 (HHV-5) Drug Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Table 1. Global Human Herpersvirus 5 (HHV-5) Drug Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Human Herpersvirus 5 (HHV-5) Drug by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Human Herpersvirus 5 (HHV-5) Drug Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Human Herpersvirus 5 (HHV-5) Drug Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Roche Corporate Information, Location and Competitors
Table 6. Roche Human Herpersvirus 5 (HHV-5) Drug Major Business
Table 7. Roche Human Herpersvirus 5 (HHV-5) Drug Total Revenue (USD Million) (2017-2018)
Table 8. Roche SWOT Analysis
Table 9. Roche Human Herpersvirus 5 (HHV-5) Drug Product and Solutions
Table 10. Roche Human Herpersvirus 5 (HHV-5) Drug Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. Haikou Kellett Corporate Information, Location and Competitors
Table 12. Haikou Kellett Human Herpersvirus 5 (HHV-5) Drug Major Business
Table 13. Haikou Kellett Human Herpersvirus 5 (HHV-5) Drug Total Revenue (USD Million) (2018-2019)
Table 14. Haikou Kellett SWOT Analysis
Table 15. Haikou Kellett Human Herpersvirus 5 (HHV-5) Drug Product and Solutions
Table 16. Haikou Kellett Human Herpersvirus 5 (HHV-5) Drug Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. Hubei Branch benefits medicine Corporate Information, Location and Competitors
Table 18. Hubei Branch benefits medicine Human Herpersvirus 5 (HHV-5) Drug Major Business
Table 19. Hubei Branch benefits medicine Human Herpersvirus 5 (HHV-5) Drug Total Revenue (USD Million) (2017-2018)
Table 20. Hubei Branch benefits medicine SWOT Analysis
Table 21. Hubei Branch benefits medicine Human Herpersvirus 5 (HHV-5) Drug Product and Solutions
Table 22. Hubei Branch benefits medicine Human Herpersvirus 5 (HHV-5) Drug Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. Livzon Pharmaceuticals Corporate Information, Location and Competitors
Table 24. Livzon Pharmaceuticals Human Herpersvirus 5 (HHV-5) Drug Major Business
Table 25. Livzon Pharmaceuticals Human Herpersvirus 5 (HHV-5) Drug Total Revenue (USD Million) (2017-2018)
Table 26. Livzon Pharmaceuticals SWOT Analysis
Table 27. Livzon Pharmaceuticals Human Herpersvirus 5 (HHV-5) Drug Product and Solutions
Table 28. Livzon Pharmaceuticals Human Herpersvirus 5 (HHV-5) Drug Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. Chongqing Winbond (acquisition of Sichuan Mingxin) Corporate Information, Location and Competitors
Table 30. Chongqing Winbond (acquisition of Sichuan Mingxin) Human Herpersvirus 5 (HHV-5) Drug Major Business
Table 31. Chongqing Winbond (acquisition of Sichuan Mingxin) Human Herpersvirus 5 (HHV-5) Drug Total Revenue (USD Million) (2017-2018)
Table 32. Chongqing Winbond (acquisition of Sichuan Mingxin) SWOT Analysis
Table 33. Chongqing Winbond (acquisition of Sichuan Mingxin) Human Herpersvirus 5 (HHV-5) Drug Product and Solutions
Table 34. Chongqing Winbond (acquisition of Sichuan Mingxin) Human Herpersvirus 5 (HHV-5) Drug Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. Sichuan Cologne Pharmaceutical Corporate Information, Location and Competitors
Table 36. Sichuan Cologne Pharmaceutical Human Herpersvirus 5 (HHV-5) Drug Major Business
Table 37. Sichuan Cologne Pharmaceutical Human Herpersvirus 5 (HHV-5) Drug Total Revenue (USD Million) (2017-2018)
Table 38. Sichuan Cologne Pharmaceutical SWOT Analysis
Table 39. Sichuan Cologne Pharmaceutical Human Herpersvirus 5 (HHV-5) Drug Product and Solutions
Table 40. Sichuan Cologne Pharmaceutical Human Herpersvirus 5 (HHV-5) Drug Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. Chongqing Fu'an Pharmaceutical Corporate Information, Location and Competitors
Table 42. Chongqing Fu'an Pharmaceutical Human Herpersvirus 5 (HHV-5) Drug Major Business
Table 43. Chongqing Fu'an Pharmaceutical Human Herpersvirus 5 (HHV-5) Drug Total Revenue (USD Million) (2017-2018)
Table 44. Chongqing Fu'an Pharmaceutical SWOT Analysis
Table 45. Chongqing Fu'an Pharmaceutical Human Herpersvirus 5 (HHV-5) Drug Product and Solutions
Table 46. Chongqing Fu'an Pharmaceutical Human Herpersvirus 5 (HHV-5) Drug Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 47. Upright and clear Corporate Information, Location and Competitors
Table 48. Upright and clear Human Herpersvirus 5 (HHV-5) Drug Major Business
Table 49. Upright and clear Human Herpersvirus 5 (HHV-5) Drug Total Revenue (USD Million) (2017-2018)
Table 50. Upright and clear SWOT Analysis
Table 51. Upright and clear Human Herpersvirus 5 (HHV-5) Drug Product and Solutions
Table 52. Upright and clear Human Herpersvirus 5 (HHV-5) Drug Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 53. GlaxoSmithKline Corporate Information, Location and Competitors
Table 54. GlaxoSmithKline Human Herpersvirus 5 (HHV-5) Drug Major Business
Table 55. GlaxoSmithKline Human Herpersvirus 5 (HHV-5) Drug Total Revenue (USD Million) (2017-2018)
Table 56. GlaxoSmithKline SWOT Analysis
Table 57. GlaxoSmithKline Human Herpersvirus 5 (HHV-5) Drug Product and Solutions
Table 58. GlaxoSmithKline Human Herpersvirus 5 (HHV-5) Drug Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 59. On the drug new Asia Corporate Information, Location and Competitors
Table 60. On the drug new Asia Human Herpersvirus 5 (HHV-5) Drug Major Business
Table 61. On the drug new Asia Human Herpersvirus 5 (HHV-5) Drug Total Revenue (USD Million) (2017-2018)
Table 62. On the drug new Asia SWOT Analysis
Table 63. On the drug new Asia Human Herpersvirus 5 (HHV-5) Drug Product and Solutions
Table 64. On the drug new Asia Human Herpersvirus 5 (HHV-5) Drug Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 65. Shandong Luo Xin Pharmaceutical Corporate Information, Location and Competitors
Table 66. Shandong Luo Xin Pharmaceutical Human Herpersvirus 5 (HHV-5) Drug Major Business
Table 67. Shandong Luo Xin Pharmaceutical Human Herpersvirus 5 (HHV-5) Drug Total Revenue (USD Million) (2017-2018)
Table 68. Shandong Luo Xin Pharmaceutical SWOT Analysis
Table 69. Shandong Luo Xin Pharmaceutical Human Herpersvirus 5 (HHV-5) Drug Product and Solutions
Table 70. Shandong Luo Xin Pharmaceutical Human Herpersvirus 5 (HHV-5) Drug Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 71. Wuhan Hualong Corporate Information, Location and Competitors
Table 72. Wuhan Hualong Human Herpersvirus 5 (HHV-5) Drug Major Business
Table 73. Wuhan Hualong Human Herpersvirus 5 (HHV-5) Drug Total Revenue (USD Million) (2017-2018)
Table 74. Wuhan Hualong SWOT Analysis
Table 75. Wuhan Hualong Human Herpersvirus 5 (HHV-5) Drug Product and Solutions
Table 76. Wuhan Hualong Human Herpersvirus 5 (HHV-5) Drug Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 77. Yangtze River Pharmaceutical Corporate Information, Location and Competitors
Table 78. Yangtze River Pharmaceutical Human Herpersvirus 5 (HHV-5) Drug Major Business
Table 79. Yangtze River Pharmaceutical Human Herpersvirus 5 (HHV-5) Drug Total Revenue (USD Million) (2017-2018)
Table 80. Yangtze River Pharmaceutical SWOT Analysis
Table 81. Yangtze River Pharmaceutical Human Herpersvirus 5 (HHV-5) Drug Product and Solutions
Table 82. Yangtze River Pharmaceutical Human Herpersvirus 5 (HHV-5) Drug Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 83. Qianjiang Pharmaceuticals Corporate Information, Location and Competitors
Table 84. Qianjiang Pharmaceuticals Human Herpersvirus 5 (HHV-5) Drug Major Business
Table 85. Qianjiang Pharmaceuticals Human Herpersvirus 5 (HHV-5) Drug Total Revenue (USD Million) (2017-2018)
Table 86. Qianjiang Pharmaceuticals SWOT Analysis
Table 87. Qianjiang Pharmaceuticals Human Herpersvirus 5 (HHV-5) Drug Product and Solutions
Table 88. Qianjiang Pharmaceuticals Human Herpersvirus 5 (HHV-5) Drug Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 89. Global Human Herpersvirus 5 (HHV-5) Drug Revenue (Million USD) by Players (2015-2020)
Table 90. Global Human Herpersvirus 5 (HHV-5) Drug Revenue Share by Players (2015-2020)
Table 91. Global Human Herpersvirus 5 (HHV-5) Drug Revenue (Million USD) by Regions (2015-2020)
Table 92. Global Human Herpersvirus 5 (HHV-5) Drug Revenue Market Share by Regions (2015-2020)
Table 93. North America Human Herpersvirus 5 (HHV-5) Drug Revenue by Countries (2015-2020)
Table 94. North America Human Herpersvirus 5 (HHV-5) Drug Revenue Market Share by Countries (2015-2020)
Table 95. Europe Human Herpersvirus 5 (HHV-5) Drug Revenue (Million USD) by Countries (2015-2020)
Table 96. Asia-Pacific Human Herpersvirus 5 (HHV-5) Drug Revenue (Million USD) by Countries (2015-2020)
Table 97. South America Human Herpersvirus 5 (HHV-5) Drug Revenue by Countries (2015-2020)
Table 98. South America Human Herpersvirus 5 (HHV-5) Drug Revenue Market Share by Countries (2015-2020)
Table 99. Middle East and Africa Human Herpersvirus 5 (HHV-5) Drug Revenue (Million USD) by Countries (2015-2020)
Table 100. Middle East and Africa Human Herpersvirus 5 (HHV-5) Drug Revenue Market Share by Countries (2015-2020)
Table 101. Global Human Herpersvirus 5 (HHV-5) Drug Revenue (Million USD) by Type (2015-2020)
Table 102. Global Human Herpersvirus 5 (HHV-5) Drug Revenue Share by Type (2015-2020)
Table 103. Global Human Herpersvirus 5 (HHV-5) Drug Revenue Forecast by Type (2021-2025)
Table 104. Global Human Herpersvirus 5 (HHV-5) Drug Revenue by Application (2015-2020)
Table 105. Global Human Herpersvirus 5 (HHV-5) Drug Revenue Share by Application (2015-2020)
Table 106. Global Human Herpersvirus 5 (HHV-5) Drug Revenue Forecast by Application (2021-2025)
Table 107. Global Human Herpersvirus 5 (HHV-5) Drug Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Human Herpersvirus 5 (HHV-5) Drug Picture
Figure 2. Global Human Herpersvirus 5 (HHV-5) Drug Revenue Market Share by Type in 2019
Figure 3. Ganciclovir Picture
Figure 4. Valerian Gilivir Drugs Picture
Figure 5. Acyclovir Drugs Picture
Figure 6. Valacyclovir Drugs Picture
Figure 7. Foscarnet Sodium Drugs Picture
Figure 8. Human Herpersvirus 5 (HHV-5) Drug Revenue Market Share by Application in 2019
Figure 9. Immunodeficiency Crowd Picture
Figure 10. Organ Transplant Crowd Picture
Figure 11. CMV Herpes Crowd Picture
Figure 12. Global Human Herpersvirus 5 (HHV-5) Drug Revenue (USD Million) and Growth Rate (2015-2025)
Figure 13. North America Human Herpersvirus 5 (HHV-5) Drug Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. Europe Human Herpersvirus 5 (HHV-5) Drug Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Asia-Pacific Human Herpersvirus 5 (HHV-5) Drug Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. South America Human Herpersvirus 5 (HHV-5) Drug Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. Middle East and Africa Human Herpersvirus 5 (HHV-5) Drug Revenue (Million USD) and Growth Rate (2015-2025)
Figure 18. Global Human Herpersvirus 5 (HHV-5) Drug Revenue (Million USD) and Growth Rate (2015-2025)
Figure 19. Global Human Herpersvirus 5 (HHV-5) Drug Revenue Share by Players in 2019
Figure 20. Global Top 5 Players Human Herpersvirus 5 (HHV-5) Drug Revenue Market Share in 2019
Figure 21. Global Top 10 Players Human Herpersvirus 5 (HHV-5) Drug Revenue Market Share in 2019
Figure 22. Key Players Market Share Trend
Figure 23. Global Human Herpersvirus 5 (HHV-5) Drug Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 24. Global Human Herpersvirus 5 (HHV-5) Drug Revenue Market Share by Regions (2015-2020)
Figure 25. Global Human Herpersvirus 5 (HHV-5) Drug Revenue Market Share by Regions in 2018
Figure 26. North America Human Herpersvirus 5 (HHV-5) Drug Revenue and Growth Rate (2015-2020)
Figure 27. Europe Human Herpersvirus 5 (HHV-5) Drug Revenue and Growth Rate (2015-2020)
Figure 28. Asia-Pacific Human Herpersvirus 5 (HHV-5) Drug Revenue and Growth Rate (2015-2020)
Figure 29. South America Human Herpersvirus 5 (HHV-5) Drug Revenue and Growth Rate (2015-2020)
Figure 30. Middle East and Africa Human Herpersvirus 5 (HHV-5) Drug Revenue and Growth Rate (2015-2020)
Figure 31. North America Human Herpersvirus 5 (HHV-5) Drug Revenue Market Share by Countries (2015-2020)
Figure 32. North America Human Herpersvirus 5 (HHV-5) Drug Revenue Market Share by Countries in 2019
Figure 33. USA Human Herpersvirus 5 (HHV-5) Drug Revenue and Growth Rate (2015-2020)
Figure 34. Canada Human Herpersvirus 5 (HHV-5) Drug Revenue and Growth Rate (2015-2020)
Figure 35. Mexico Human Herpersvirus 5 (HHV-5) Drug Revenue and Growth Rate (2015-2020)
Figure 36. Europe Human Herpersvirus 5 (HHV-5) Drug Revenue Market Share by Countries (2015-2020)
Figure 37. Europe Human Herpersvirus 5 (HHV-5) Drug Revenue Market Share by Countries in 2019
Figure 38. Germany Human Herpersvirus 5 (HHV-5) Drug Revenue and Growth Rate (2015-2020)
Figure 39. UK Human Herpersvirus 5 (HHV-5) Drug Revenue and Growth Rate (2015-2020)
Figure 40. France Human Herpersvirus 5 (HHV-5) Drug Revenue and Growth Rate (2015-2020)
Figure 41. Russia Human Herpersvirus 5 (HHV-5) Drug Revenue and Growth Rate (2015-2020)
Figure 42. Italy Human Herpersvirus 5 (HHV-5) Drug Revenue and Growth Rate (2015-2020)
Figure 43. Asia-Pacific Human Herpersvirus 5 (HHV-5) Drug Revenue Market Share by Countries (2015-2020)
Figure 44. Asia-Pacific Human Herpersvirus 5 (HHV-5) Drug Revenue Market Share by Countries in 2019
Figure 45. China Human Herpersvirus 5 (HHV-5) Drug Revenue and Growth Rate (2015-2020)
Figure 46. Japan Human Herpersvirus 5 (HHV-5) Drug Revenue and Growth Rate (2015-2020)
Figure 47. Korea Human Herpersvirus 5 (HHV-5) Drug Revenue and Growth Rate (2015-2020)
Figure 48. India Human Herpersvirus 5 (HHV-5) Drug Revenue and Growth Rate (2015-2020)
Figure 49. Southeast Asia Human Herpersvirus 5 (HHV-5) Drug Revenue and Growth Rate (2015-2020)
Figure 50. South America Human Herpersvirus 5 (HHV-5) Drug Revenue Market Share by Countries (2015-2020)
Figure 51. South America Human Herpersvirus 5 (HHV-5) Drug Revenue Market Share by Countries in 2019
Figure 52. Brazil Human Herpersvirus 5 (HHV-5) Drug Revenue and Growth Rate (2015-2020)
Figure 53. Argentina Human Herpersvirus 5 (HHV-5) Drug Revenue and Growth Rate (2015-2020)
Figure 54. Middle East and Africa Human Herpersvirus 5 (HHV-5) Drug Revenue Market Share by Countries (2015-2020)
Figure 55. Middle East and Africa Human Herpersvirus 5 (HHV-5) Drug Revenue Market Share by Countries in 2019
Figure 56. Saudi Arabia Human Herpersvirus 5 (HHV-5) Drug Revenue and Growth Rate (2015-2020)
Figure 57. UAE Human Herpersvirus 5 (HHV-5) Drug Revenue and Growth Rate (2015-2020)
Figure 58. Egypt Human Herpersvirus 5 (HHV-5) Drug Revenue and Growth Rate (2015-2020)
Figure 59. South Africa Human Herpersvirus 5 (HHV-5) Drug Revenue and Growth Rate (2015-2020)
Figure 60. Global Human Herpersvirus 5 (HHV-5) Drug Revenue Share by Type (2015-2020)
Figure 61. Global Human Herpersvirus 5 (HHV-5) Drug Revenue Share by Type in 2019
Figure 62. Global Human Herpersvirus 5 (HHV-5) Drug Market Share Forecast by Type (2021-2025)
Figure 63. Global Ganciclovir Revenue Growth Rate (2015-2020)
Figure 64. Global Valerian Gilivir Drugs Revenue Growth Rate (2015-2020)
Figure 65. Global Acyclovir Drugs Revenue Growth Rate (2015-2020)
Figure 66. Global Valacyclovir Drugs Revenue Growth Rate (2015-2020)
Figure 67. Global Foscarnet Sodium Drugs Revenue Growth Rate (2015-2020)
Figure 68. Global Human Herpersvirus 5 (HHV-5) Drug Revenue Share by Application (2015-2020)
Figure 69. Global Human Herpersvirus 5 (HHV-5) Drug Revenue Share by Application in 2019
Figure 70. Global Human Herpersvirus 5 (HHV-5) Drug Market Share Forecast by Application (2021-2025)
Figure 71. Global Immunodeficiency Crowd Revenue Growth Rate (2015-2020)
Figure 72. Global Organ Transplant Crowd Revenue Growth Rate (2015-2020)
Figure 73. Global CMV Herpes Crowd Revenue Growth Rate (2015-2020)
Figure 74. Global Human Herpersvirus 5 (HHV-5) Drug Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 75. Global Human Herpersvirus 5 (HHV-5) Drug Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 76. Global Human Herpersvirus 5 (HHV-5) Drug Revenue Market Share Forecast by Regions (2021-2025)
Figure 77. North America Human Herpersvirus 5 (HHV-5) Drug Revenue Market Forecast (2021-2025)
Figure 78. Europe Human Herpersvirus 5 (HHV-5) Drug Revenue Market Forecast (2021-2025)
Figure 79. Asia-Pacific Human Herpersvirus 5 (HHV-5) Drug Revenue Market Forecast (2021-2025)
Figure 80. South America Human Herpersvirus 5 (HHV-5) Drug Revenue Market Forecast (2021-2025)
Figure 81. Middle East and Africa Human Herpersvirus 5 (HHV-5) Drug Revenue Market Forecast (2021-2025)
Figure 82. Sales Channel: Direct Channel vs Indirect Channel
薬物＆遺伝子デリバリーデバイスの世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Drug And Gene Delivery Devices market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 3.7% in the forecast period of 2020 to 2025 and will expected to reach USD 591860 million by 2025, from USD 510940 million in 2019. The Drug …- 治療薬モニタリングの世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Therapeutic Drug Monitoring market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 3.2% in the forecast period of 2020 to 2025 and will expected to reach USD 1227.9 million by 2025, from USD 1082.5 million in 2019. The Therapeu…
- 内分泌系薬の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Endocrine System Drug market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Endocrine System Drug m…
- ヒトエンドスタチンの世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Human Endostatin market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Human Endostatin market repo…
- 眼科用薬品の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Ophthalmol Drug market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Ophthalmol Drug market report…